Jan 5, 2016 01:09
8 yrs ago
2 viewers *
Serbian term
SPD
Serbian to English
Medical
Medical (general)
Kidney dialysis
"Kod bolesnice nova pojava zamućenog dijalizata PD a u SPD-u dosta leukocita."
This appears in a Serbian hospitalisation report for a kidney failure patient on peritoneal dialysis (PD). I don't know the meaning of SPD, which apparently has a high leukocyte count due to bacteria-caused peritonitis. If it helps, in a lab report further down I find 'high leukocyte count' in SPD I, II and III. I would be grateful for any ideas.
By the way, I am translating into English.
This appears in a Serbian hospitalisation report for a kidney failure patient on peritoneal dialysis (PD). I don't know the meaning of SPD, which apparently has a high leukocyte count due to bacteria-caused peritonitis. If it helps, in a lab report further down I find 'high leukocyte count' in SPD I, II and III. I would be grateful for any ideas.
By the way, I am translating into English.
Proposed translations
(English)
4 | PDS (peritoneal dialysis sediment) | Marko Bukurov |
4 | spermidin | NadaM |
References
non-definitive findings | liz askew |
Proposed translations
14 hrs
Selected
PDS (peritoneal dialysis sediment)
SPD = sediment perifernog dijalizata
4 KudoZ points awarded for this answer.
Comment: "Thank you, this seems to be the most suitable answer in the context."
13 hrs
spermidin
to je vec na engleskom, tj. ista se skracenica koristi (spermidine = SPD)
Reference:
Note from asker:
Hvala, savrseno odgovara u kontekstu. |
Reference comments
14 hrs
Reference:
non-definitive findings
http://www.ncbi.nlm.nih.gov/pubmed/25338415
--------------------------------------------------
Note added at 14 hrs (2016-01-05 15:43:44 GMT)
--------------------------------------------------
SPD can = Subcutaneous pathway diversion
--------------------------------------------------
Note added at 14 hrs (2016-01-05 15:46:20 GMT)
--------------------------------------------------
http://www.advancesinpd.com/adv88/pt4prognositc88.html
SPD = standard peritoneal dialysis
--------------------------------------------------
Note added at 14 hrs (2016-01-05 15:48:36 GMT)
--------------------------------------------------
Abstract
Peritoneal dialysis (PD) catheter-related infection is still is the most troublesome problem for continuation of PD without the need to switch to hemodialysis. We have been performing subcutaneous pathway diversion (SPD) as a surgical treatment for refractory exit-site and tunnel infection (ESTI). To clarify the efficacy and safety of SPD, we conducted a retrospective study. From August 2008 to August 2013, 30 SPDs were performed in 26 patients (16 men, 10 women; mean age: 58 +/- 13 years; 54% with diabetes; mean body mass index: 23.9 +/- 3.5 kg/ m2). The reasons for the SPDs were ESTI in 25 patients, and outer cuff extrusion in 1 patient. All patients resumed PD immediately after SPD, and the duration of hospitalization was 11.7 +/- 10.1 days. After SPD, one patient experienced a dialysate leak, and another patient experienced a mild subcutaneous hematoma. Another 4 patients developed exit-site infection (ESI) and underwent a second SPD. Of those 4 patients, 3 presented with another ESI unrelated to the first episode, and all developed an ESI after 6 months or more. The remaining 20 patients experienced no such complications. Furthermore, catheter survival after SPD was 17.4 +/- 13.4 months. To eradicate ESTTI we suggest that SPD, which does not require catheter removal or interruption of PD, is useful compared with the unroofing technique or catheter removal.
--------------------------------------------------
Note added at 14 hrs (2016-01-05 15:43:44 GMT)
--------------------------------------------------
SPD can = Subcutaneous pathway diversion
--------------------------------------------------
Note added at 14 hrs (2016-01-05 15:46:20 GMT)
--------------------------------------------------
http://www.advancesinpd.com/adv88/pt4prognositc88.html
SPD = standard peritoneal dialysis
--------------------------------------------------
Note added at 14 hrs (2016-01-05 15:48:36 GMT)
--------------------------------------------------
Abstract
Peritoneal dialysis (PD) catheter-related infection is still is the most troublesome problem for continuation of PD without the need to switch to hemodialysis. We have been performing subcutaneous pathway diversion (SPD) as a surgical treatment for refractory exit-site and tunnel infection (ESTI). To clarify the efficacy and safety of SPD, we conducted a retrospective study. From August 2008 to August 2013, 30 SPDs were performed in 26 patients (16 men, 10 women; mean age: 58 +/- 13 years; 54% with diabetes; mean body mass index: 23.9 +/- 3.5 kg/ m2). The reasons for the SPDs were ESTI in 25 patients, and outer cuff extrusion in 1 patient. All patients resumed PD immediately after SPD, and the duration of hospitalization was 11.7 +/- 10.1 days. After SPD, one patient experienced a dialysate leak, and another patient experienced a mild subcutaneous hematoma. Another 4 patients developed exit-site infection (ESI) and underwent a second SPD. Of those 4 patients, 3 presented with another ESI unrelated to the first episode, and all developed an ESI after 6 months or more. The remaining 20 patients experienced no such complications. Furthermore, catheter survival after SPD was 17.4 +/- 13.4 months. To eradicate ESTTI we suggest that SPD, which does not require catheter removal or interruption of PD, is useful compared with the unroofing technique or catheter removal.
Something went wrong...